Harbour BioMed announced today it has entered into a multi-year, multifaceted research collaboration agreement with Dana-Farber Cancer Institute to co-develop novel biotherapies in cancer treatment.
Eli Lilly must be seeing value in its broad-ranging research collaboration with the Dana-Farber Cancer Institute, as it’s extending the partnership for another three years.
The Global Foundation for Human Aging Research announces a donation of $75,000 to Dana-Farber Cancer Institute, the cancer treatment and research center designated by the National Cancer Institute in Boston, MA, and affiliate of Harvard Medical School.